Cancer News and Research

Latest Cancer News and Research

New Australian drug approvals subject to budget cuts

According to Health Minister Nicola Roxon’s statement to pharmaceutical company bosses, new medicines will no longer be subsidised unless budget savings can be found.

9 Mar 2011

Older men have higher risk of melanoma: Australian study

Health experts warn that the rates of skin cancer – melanoma, is on the rise among elderly Victorians. This came out as new figures were released yesterday by Cancer Council Victoria that showed that Victorians aged over 55 accounted for two-thirds of melanoma diagnoses, and rural men were at highest risk. In 2008 a total of 2217 Victorians were diagnosed with melanoma and 279 people died. Skin cancer rates have increased by 400 per cent in the past 26 years among older males.

9 Mar 2011

Keneally promises billions for hospital & healthcare upgrades

Hospital upgrades with more beds and an expansion of the nursing and medical workforce may be a reality in the near future thanks to the Keneally government’s $2.3 billion pitch. Premier Kristina Keneally pledged the total spending package of $4bn would deliver “improvements right across the health system” and give patients the care they needed, promptly. She spoke at the launch at the Children’s Hospital at Westmead in Sydney’s west saying, “This is about strengthening our health system to deal with challenges of an ageing population, growing levels of chronic disease and rising health costs.”

9 Mar 2011

ERYtech Pharma completes patient enrollment in GRASPA Phase II trial against ALL

ERYtech Pharma announces the early completion of the enrollment and safety follow-up a Phase II clinical trial for GRASPA. This open-labeled trial introduced GRASPA in a first-line treatment for Acute Lymphoblastic Leukemia in patients older than 55 years.

9 Mar 2011

Alliance fourth quarter revenue decreases to $117.7 million

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the fourth quarter and year ended December 31, 2010.

9 Mar 2011

Adamis submits APC-100 IND to FDA for treatment of prostate cancer

Adamis Pharmaceuticals Corporation announced today that it has recently submitted to the FDA an Investigational New Drug application for APC-100 to treat prostate cancer.

9 Mar 2011

Fluidigm fourth quarter revenue increases to $10.4 million

Fluidigm Corporation today announced its financial results for the fourth quarter and full year ended December 31, 2010.

9 Mar 2011

MHQP reports significant differences in quality of care delivered by Massachusetts medical groups

Massachusetts Health Quality Partners announced today that despite improvement, there are significant differences in the quality of care delivered by medical groups in Massachusetts, according to its annual Quality Insights: Clinical Quality in Primary Care report.

9 Mar 2011

ADVANTAGE, ITA to implement proprietary oncology decision-support platform

To improve outcomes and manage costs for members with cancer, ADVANTAGE Health Solutions, Inc. has contracted with ITA Partners to implement eviti - ITA's proprietary oncology decision-support platform - across their provider network.

9 Mar 2011

Vertex to present telaprevir and VX-222 study results against hepatitis C at EASL annual meeting

Vertex Pharmaceuticals Incorporated announced today that 15 abstracts on the company's medicines in development for hepatitis C, including its protease inhibitor, telaprevir, and polymerase inhibitor, VX-222, were accepted for presentation at the 46th Annual Meeting of the European Association for the Study of the Liver in Berlin, Germany, March 30 to April 3, 2011.

9 Mar 2011

MD Solarsciences launches new sunscreen lotion at 2011 AAD meeting

A year after its launch, the first dermatologist-driven company dedicated to primary skin cancer protection and prevention introduced its newest solar protection product -- a much-anticipated tinted mineral gel sunscreen – at the 2011 AAD meeting in New Orleans.

9 Mar 2011

Vermillion's CA125 positive preliminary data against ovarian tumors presented at WCSGO

Vermillion, a molecular diagnostics company, today announced the presentation of positive preliminary data from its collaboration with Johns Hopkins University School of Medicine to identify biomarkers that improve on the specificity of CA125 for the identification of malignant ovarian tumors.

9 Mar 2011

Oral magnesium oxide is a safe treatment for children with chronic constipation

Magnesium-containing cathartics are commonly used to treat chronic constipation. Although hypermagnesemia is a rare clinical condition, it can occur as a side effect of increased intake of magnesium salts.

9 Mar 2011

RainDance, 454 Life Sciences collaborate to launch core ADME gene screening research panel

RainDance Technologies, Inc., and 454 Life Sciences, a Roche Company, today announced a collaboration for the development and commercialization of a targeted next-generation sequencing (NGS) solution for the simple and cost-effective investigation of drug absorption, distribution, metabolism, and excretion (ADME).

9 Mar 2011

MabCure presents ovarian cancer diagnostic blood test study results at SGO meeting

Biotechnology company MabCure, Inc. is presenting the results of its recently completed study on the diagnosis of ovarian cancer utilizing its proprietary monoclonal antibodies at the annual meeting of the Society of Gynecological Oncologists.

9 Mar 2011

Study supports DNA mismatch repair test for bowel cancer

Bowel cancer patients whose tumors contain defects in specific DNA repair systems are much less likely to experience tumour recurrence post surgery, results from a major clinical study have demonstrated.

9 Mar 2011

New study shows excess hospitalization costs for homeless people

Homeless patients cost about $2,500 more per hospital stay than the average patient, according to a new study by researchers at St. Michael's Hospital.

9 Mar 2011

PIVI document examines endoscopic assessment of diminutive colorectal polyps

In recognition of National Colorectal Cancer Awareness Month during March, GIE: Gastrointestinal Endoscopy has put out a special issue for March on colonoscopy and colorectal cancer.

9 Mar 2011

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

9 Mar 2011

First urinary metabolomic investigation in gastric cancer using gas chromatography/mass spectrometry

Metabolomics is a post-genomic research field for analysis of low molecular weight compounds in biological systems, and its approaches offer an analysis of metabolite level changes in biological samples. Recently, metabolomic method has shown great potentials in identifying the new diagnostic markers and therapeutic targets for cancers. However, metabolomic studies on cancer metastasis remain scarce.

9 Mar 2011

Cancer News and Research

Latest Cancer News and Research

New Australian drug approvals subject to budget cuts

Older men have higher risk of melanoma: Australian study

Keneally promises billions for hospital & healthcare upgrades

ERYtech Pharma completes patient enrollment in GRASPA Phase II trial against ALL

Alliance fourth quarter revenue decreases to $117.7 million

Adamis submits APC-100 IND to FDA for treatment of prostate cancer

Fluidigm fourth quarter revenue increases to $10.4 million

MHQP reports significant differences in quality of care delivered by Massachusetts medical groups

ADVANTAGE, ITA to implement proprietary oncology decision-support platform

Vertex to present telaprevir and VX-222 study results against hepatitis C at EASL annual meeting

MD Solarsciences launches new sunscreen lotion at 2011 AAD meeting

Vermillion's CA125 positive preliminary data against ovarian tumors presented at WCSGO

Oral magnesium oxide is a safe treatment for children with chronic constipation

RainDance, 454 Life Sciences collaborate to launch core ADME gene screening research panel

MabCure presents ovarian cancer diagnostic blood test study results at SGO meeting

Study supports DNA mismatch repair test for bowel cancer

New study shows excess hospitalization costs for homeless people

PIVI document examines endoscopic assessment of diminutive colorectal polyps

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

First urinary metabolomic investigation in gastric cancer using gas chromatography/mass spectrometry

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in